Flagship Harbor Advisors, LLC Reviva Pharmaceuticals Holdings, Inc. Transaction History
Flagship Harbor Advisors, LLC
- $1.94 Billion
- Q4 2025
A detailed history of Flagship Harbor Advisors, LLC transactions in Reviva Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Flagship Harbor Advisors, LLC holds 12,530 shares of RVPH stock, worth $6,265. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,530Holding current value
$6,265% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RVPH
# of Institutions
51Shares Held
9.75MCall Options Held
585KPut Options Held
31.6K-
Diadema Partners LP Morristown, NJ2.51MShares$1.25 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.92MShares$961,6140.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.71MShares$855,6100.0% of portfolio
-
Persistent Asset Partners LTD Hong Kong, K3594KShares$296,9510.15% of portfolio
-
Geode Capital Management, LLC Boston, MA559KShares$279,6210.0% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $10.2M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...